Tokio Marine Asset Management Co. Ltd. increased its position in Heska Corporation (NASDAQ:HSKA) by 76.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,400 shares of the medical research company’s stock after buying an additional 1,900 shares during the period. Tokio Marine Asset Management Co. Ltd. owned 0.06% of Heska Corporation worth $388,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in the stock. Crossmark Global Holdings Inc. acquired a new position in Heska Corporation in the third quarter worth approximately $336,000. Raymond James Trust N.A. grew its holdings in Heska Corporation by 6.5% during the third quarter. Raymond James Trust N.A. now owns 8,953 shares of the medical research company’s stock valued at $789,000 after purchasing an additional 543 shares during the last quarter. Albion Financial Group UT grew its holdings in Heska Corporation by 1.3% during the second quarter. Albion Financial Group UT now owns 6,421 shares of the medical research company’s stock valued at $655,000 after purchasing an additional 80 shares during the last quarter. Susquehanna International Group LLP acquired a new position in Heska Corporation during the second quarter valued at approximately $854,000. Finally, The Manufacturers Life Insurance Company grew its holdings in Heska Corporation by 6.1% during the second quarter. The Manufacturers Life Insurance Company now owns 5,112 shares of the medical research company’s stock valued at $522,000 after purchasing an additional 294 shares during the last quarter. Hedge funds and other institutional investors own 78.58% of the company’s stock.
Several equities research analysts have recently issued reports on HSKA shares. B. Riley lowered their price objective on shares of Heska Corporation from $96.50 to $93.00 and set a “neutral” rating on the stock in a research note on Friday, November 3rd. Canaccord Genuity started coverage on shares of Heska Corporation in a research note on Thursday, October 5th. They issued a “buy” rating and a $115.00 price objective on the stock. Zacks Investment Research downgraded shares of Heska Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. BidaskClub cut Heska Corporation from a “buy” rating to a “hold” rating in a research report on Monday, August 14th. Finally, Benchmark Co. reaffirmed a “buy” rating and issued a $120.00 target price (up from $106.00) on shares of Heska Corporation in a research report on Wednesday, August 9th. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $106.25.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.truebluetribune.com/2017/11/14/tokio-marine-asset-management-co-ltd-has-388000-stake-in-heska-corporation-hska.html.
In other news, CFO John Mcmahon sold 2,608 shares of Heska Corporation stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $101.17, for a total transaction of $263,851.36. Following the transaction, the chief financial officer now owns 193 shares in the company, valued at approximately $19,525.81. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Nancy Wisnewski sold 825 shares of Heska Corporation stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $102.21, for a total value of $84,323.25. Following the transaction, the executive vice president now owns 38,114 shares in the company, valued at approximately $3,895,631.94. The disclosure for this sale can be found here. 14.70% of the stock is currently owned by insiders.
Heska Corporation (NASDAQ:HSKA) opened at $85.55 on Tuesday. The stock has a market capitalization of $616.95, a PE ratio of 44.59, a P/E/G ratio of 2.27 and a beta of 0.83. Heska Corporation has a twelve month low of $61.95 and a twelve month high of $115.00.
Heska Corporation (NASDAQ:HSKA) last announced its quarterly earnings data on Thursday, November 2nd. The medical research company reported $0.40 EPS for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.03. The firm had revenue of $31.40 million during the quarter, compared to analyst estimates of $36.10 million. Heska Corporation had a return on equity of 15.35% and a net margin of 10.67%. The company’s revenue was down 6.0% on a year-over-year basis. During the same period last year, the company earned $0.45 earnings per share. equities analysts predict that Heska Corporation will post 2.03 EPS for the current fiscal year.
Heska Corporation Company Profile
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.